These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7544837)

  • 1. "Wildcatting" for breakthroughs in urothelial cancer detection and management--a frustrating business.
    Walther PJ
    J Urol; 1995 Oct; 154(4):1348-50. PubMed ID: 7544837
    [No Abstract]   [Full Text] [Related]  

  • 2. [Urothelial tumors].
    Irani J; Bernardini S; Bonnal JL; Coloby P; Colombel M; Davin JL; Laurent G; Lebret T; Maidenberg M; Mazerolles C; Pariente JL; Pfister C; Roy C; Saint F; Theodore C;
    Prog Urol; 2004 Nov; 14(4 Suppl 1):957, 959-96. PubMed ID: 15779655
    [No Abstract]   [Full Text] [Related]  

  • 3. Follow-up imaging of bladder carcinoma. American College of Radiology. ACR Appropriateness Criteria.
    Segal AJ; Amis ES; Bigongiari LR; Bluth EI; Bush WH; Choyke PL; Fritzsche PJ; Holder LE; Newhouse JH; Sandler CM; Resnick MI; Rutsky EA
    Radiology; 2000 Jun; 215 Suppl():765-72. PubMed ID: 11037498
    [No Abstract]   [Full Text] [Related]  

  • 4. [Urothelial carcinoma].
    Jakse G; Studer U; Rübben H
    Urologe A; 2001 Nov; 40(6):441. PubMed ID: 11760345
    [No Abstract]   [Full Text] [Related]  

  • 5. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
    Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transitional cell carcinoma: an overview.
    Droller MJ
    Urol Clin North Am; 1980 Oct; 7(3):519-21. PubMed ID: 7006184
    [No Abstract]   [Full Text] [Related]  

  • 7. [Urinary cytology. Possibilities, limitations and the future].
    Zaak D; Tritschler S; Knuechel R; Vom Dorp F; Hakenberg OW; Hautmann S; Rübben H
    Urologe A; 2006 Sep; 45 Suppl 4():97-101. PubMed ID: 16821054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardiac metastasis of a recurrent urothelial carcinoma of the bladder].
    Schreiner M; Schneider B; Pauls S
    Rofo; 2015 Dec; 187(12):1124-6. PubMed ID: 26425856
    [No Abstract]   [Full Text] [Related]  

  • 9. Urothelial tumors detected by cytology: new cell block technique.
    Constantian HM; De Girolami E
    J Urol; 1973 Feb; 109(2):304-7. PubMed ID: 4119599
    [No Abstract]   [Full Text] [Related]  

  • 10. Upper tract urothelial carcinoma.
    Jewett MA
    J Urol; 2006 Jan; 175(1):12-3. PubMed ID: 16406860
    [No Abstract]   [Full Text] [Related]  

  • 11. Editorial: urothelial tumors--liberal applications of conservative approaches.
    Droller MJ
    J Urol; 2003 Mar; 169(3):936-7. PubMed ID: 12576816
    [No Abstract]   [Full Text] [Related]  

  • 12. p53 and bladder cancer.
    Li WW; Li VW; Tsakayannis D
    N Engl J Med; 1995 Apr; 332(14):957; author reply 958. PubMed ID: 7794332
    [No Abstract]   [Full Text] [Related]  

  • 13. p53 and bladder cancer.
    Xing X
    N Engl J Med; 1995 Apr; 332(14):957-8. PubMed ID: 7877657
    [No Abstract]   [Full Text] [Related]  

  • 14. Urothelial carcinoma of the bladder and the upper tract: disparate twins.
    Green DA; Rink M; Xylinas E; Matin SF; Stenzl A; Roupret M; Karakiewicz PI; Scherr DS; Shariat SF
    J Urol; 2013 Apr; 189(4):1214-21. PubMed ID: 23023150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 and bladder cancer.
    Wood LL
    N Engl J Med; 1995 Apr; 332(14):958. PubMed ID: 7877658
    [No Abstract]   [Full Text] [Related]  

  • 16. Urinary modified nucleosides as novel biomarkers for diagnosis and prognostic monitoring of urothelial bladder cancer.
    Zhang YR; Shi L; Wu H; Tang DD; Wang SM; Liu HM; Zhang LR; Song DK
    Tumori; 2014; 100(6):660-6. PubMed ID: 25688500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applications of spectroscopy in diagnosis, staging, and treatment of urologic malignancies.
    Seltz LM; Herrell SD
    Curr Opin Urol; 2016 May; 26(3):259-63. PubMed ID: 26914060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Non-invasive urine tests in diagnosis and as prognostic markers for urinary bladder carcinoma. Comparison of the BTAstat and NMP 22 tests with immunocytology using monoclonal antibodies against Lewis X and 486p3/12].
    Friedrich MG; Hellstern A; Hautmann SH; Noldus I; Huland H
    Urologe A; 2003 Apr; 42(4):523-30. PubMed ID: 12715124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follow up of bladder cancer--the use of screening tests in predicting asymptomatic recurrence.
    Moran BJ; Davies PR; Twoomey PA
    J R Coll Gen Pract; 1988 Sep; 38(314):422. PubMed ID: 3256659
    [No Abstract]   [Full Text] [Related]  

  • 20. Urinary beta-glucuronidase in screening and followup of primary urinary tract malignancy.
    Ho KJ
    J Urol; 1995 Oct; 154(4):1335-8. PubMed ID: 7658533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.